psoriatic arthritis / rheumatism rheumatism
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: - Newly diagnosed psoriatic arthritis - Aged > 17 years
Exclusion criteria
Exclusion criteria: - Unable to give informed consent. - Not being able to understand, speak and write in Dutch - Treatment with DMARDs or corticosteroids for arthritis/enthesitis/dactylitis in the period between PsA diagnosis and the first study visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| What is the impact of *time to minimal disease activity* on quality of life, work participation and radiographic joint damage at 2 year follow up in patients newly diagnosed with PsA? | — |
Secondary
| Measure | Time frame |
|---|---|
| What is the frequency of MDA in the first year after diagnosis? Which medication is used in the first year after diagnosis? Which type of medication results in early MDA? Which subtypes of PsA are associated with poor longterm outcome? What is the impact of *time to minimal disease activity* on quality of life, work participation and radiographic joint damage at 1, 3, 6 and 10 year follow- up in patients newly diagnosed with PsA? | — |
Countries
Netherlands
Contacts
Public ContactM. Vis
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed